2016 International Congress Archives - Page 149 of 207

TAF1 and its isoforms is underexpressed in different endogenous models of X-linked dystonia-parkinsonism

A. Domingo, K. Grütz, P. Seibler, P. Capetian, L.V. Lee, R. Rosales, R.D. Jamora, A. Westenberger, A. Rakovic, C. Klein (Lübeck, Germany)
Taking specialist clinics into community nursing homes

T. Williams, S. Mahon, C. Thomas, B. Mohamed (Cardiff, United Kingdom)
Targeted over-expression with AAV-mediated human α-synuclein in a rat model of Parkinson’s disease – Validation of novel fine motor functional effects

R. Pussinen, T. Ahtoniemi, T. Huhtala, O. Kontkanen, A. Nurmi (Kuopio, Finland)
Targeting PDE7 by the small molecule S14: A potential disease-modifying Parkinson�s disease therapy ready to start clinical trials

A. Martinez, C. Gil, D. Lopez Ribas, E. Cunchillos, J. Domenech, M. Sarasa (Madrid, Spain)
Targeting TLR4 for disease modification in multiple system atrophy: Experimental evidence

S. Venezia, V. Refolo, N. Stefanova (Innsbruck, Austria)
Tau dysfunction in the basal ganglia of a mouse model of tauopathy related to PSP

A. Damianich, M. Sartor, S. Espindola, I.R.E. Taravini, O.S. Gershanik, J.E. Ferrario, M. Avale (Buenos Aires, Argentina)
Tau pathology in Huntington’s disease: A brief in vivo PET-imaging report

K. Giehl, K. Reetz, I. Dogan, C. Werner, J.B. Schulz, A. Drzezga, T. van Eimeren (Köln, Germany)
Tau PET in Parkinson syndromes. A new diagnostic tool?

J. Hammes, G.N. Bischof, K. Giehl, Ö. Onur, A. Drzezga, T. Klockgether, T. van Eimeren (Cologne, Germany)
Tear fluid as potential biomarker for the diagnosis of Parkinson’s disease

M. Börger, S. Funke, F. Maaß, A. Fischbach, M. Bähr, F. Grus, P. Lingor (Göttingen, Germany)
Technology use and impulse control disorders (ICDs) in patients with Parkinson’s disease (PD)

E.A. Byrd, C.M. Tanner, C.A. Racine, N.B. Galifianakis (San Francisco, CA, USA)
Technology use habits and preferences of a population with Parkinson’s disease and their care partners

J.M. Dean (Boulder, CO, USA)
Telemedicine facilitates efficient and safe home titration of levodopa/carbidopa intestinal gel (LCIG) in patients with advanced Parkinson’s disease

T. Willows, N. Dizdar, D. Nyholm, H. Widner, P. Grenholm, U. Schmiauke, A. Urbom, K. Groth, J. Larsson, J. Permert, S. Kjellander (Huddinge, Sweden)
Temporal course of the total motor score in Huntington disease

P. Auinger, T.J. Felong, S. Gandhi, V. Abler, K. Biglan, S. Papapetropoulos, C. Venuto, R. Dorsey (Rochester, NY, USA)
Temporal course of the UHDRS chorea score in Huntington disease

T.J. Felong, P. Auinger, S. Gandhi, V. Abler, K. Biglan, S. Papapetropoulos, C. Venuto, R. Dorsey (Rochester, NY, USA)
Temporal discrimination threshold and the menstrual cycle

E.M. Mc Govern, E. O'Connor, I. Beiser, L. Williams, J.S. Butler, B. Quinlivan, R. Reilly, S. O'Riordan, M. Hutchinson (Dublin, Ireland)
Temporal dynamics of pallidal low-frequency oscillations in dystonia

D.A.I. Pina-Fuentes, J.C. van Zijl, J.W. Elting, G. Drost, J.M. van Dijk, M.A. Tijssen, M. Beudel (Groningen, Netherlands)
Temporal working memory deficit in Parkinson’s disease

B. Degos, I. Ameqrane, S. Rivaud-Péchoux, P. Pouget, M. Missal (Paris, France)
Testing candidate transcriptional biomarkers of asymtpomatic and symptomatic stages in spinocerebellar ataxia type 3 (SCA3)

M. Raposo, C. Bettencourt, M. Lima (Ponta Delgada, Portugal)
Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease

J. Carter, N. Hellmers, A. Hanineva, C. Henchcliffe (New York, NY, USA)
Testing for the “whack-a-mole” sign in the movement disorders clinic

J.E. Park, C. Maurer, M. Villegas, M. Hallett (Bethesda, MD, USA)
Thalamic deep brain stimulation for cerebellar outflow tremor and midbrain tremor: a case series

P. Anprasertporn, B.L. Guthrie, H.C. Walker (Birmingham, AL, USA)
Thalamic-subthalamic deep brain stimulation for refractory orthostatic tremor: A report of 3 cases

D. Athauda, D. Georgiev, I. Iciar Aviles-Olmos, A. Peters, B. Day, P. Brown, L. Zrinzo, M. Hariz, P. Limousin, T. Foltynie (London, United Kingdom)
The aetiology of idiopathic late onset cerebellar ataxia

R. Barbosa, M. Mendonça, T. Lampreia, P. Bugalho (Lisboa, Portugal)
The alterations in behavioral memory for prolongation disease duration in patients with Parkinson’s disease

M. Saruwatari, Y. Kobayashi, A. Kumon, K. Hasegawa (Sagamihara, Japan)
The anatomical basis of genetic dystonia: A multimodal MRI study

E. Sarasso, F. Agosta, A. Tomic, S. Basaia, N. Dragasevic, M. Svetel, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)
The application of mobile health technology to increase physical activity in persons with Parkinson’s disease

T.D. Ellis, T.R. DeAngelis, K. Hendron, J.T. Cavanaugh, N. Sullivan, L. Goehring, C.A. Thomas, M. Saint-Hilaire, N.K. Latham (Boston, MA, USA)
The assessment of quality of life in patients with early and moderately advanced Huntington disease

N. Szejko, L. Milanowski, A. Gogol, Z. Jamrozik, P. Janik (Warsaw, Poland)
The association between objectively measured physical activity and health-related-quality of life in people with Parkinson’s disease

J.M.T. Van Uem, I. Liepelt-Scarfone, B. Cerff, M. Kampmeyer, J. Prinzen, M. Zuidema, M.A. Hobert, S. Hucker, S. Del Din, S. Gräber, D. Berg, W. Maetzler (Tübingen, Germany)
The association between structural brain connectivity with plasma APO-A1 levels in Parkinson’s disease: Connectometry approach

F. Rahmani, M.H. Aarabi (Tehran, Islamic Republic of Iran)
The basal ganglia muscarine receptors impairment in progressive supranuclear palsy

B. Muinjonov, E. Giyaziddinova, G. Rakhimbaeva (Tashkent, Uzbekistan)
The care needs project: Understanding the experience of people with Parkinson’s in institutional care and understanding the care needs of people with Parkinson’s

A. Hand, R.W. Walker, W.K. Gray, L.L. Oates (North Shields, United Kingdom)
The Catalan multiple system atrophy-registry (CMSAR)

F. Antonelli, E. Muñoz, J. Pagonabarraga, J. Hernández-Vara, A. Bayes, O. de Fabregues, F. Valldeoriola, E. Tolosa, Y. Compta, M. Ezquerra, R. Fernandez, M. Calopa, S. Jauma, M. Pujol, V. Puente, A. Cámara, L. Planellas, M.J. Martí (Barcelona, Spain)
The cerebral structural and functional signatures of impulse control disorder in Parkinson’s disease

F. Imperiale, F. Agosta, E. Canu, V. Špica, M. Jecmenica, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)
The changing profile of informal carers for people with Parkinson’s with disease progression

A. Hand, R.W. Walker, W. Gray, K. Baker (North Shields, United Kingdom)
The clinical benefit of pallidal stimulation in dystonia is related to the electrode position in the medio-lateral direction

R. Jech, A. Fecíková, D. Štastná, T. Serranová, D. Urgošík, F. Ruzicka (Prague 2, Czech Republic)
The clinical characteristics of Lewy body disease showed autonomic failures preceding motor signs

A. Miyake, T. Yamamoto, K. Ikeda, T. Furuya, M. Takashi, Y. Ito, Y. Nakazato, N. Tamura, N. Araki (Irumagun Moroyama Town, Japan)
The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson’s disease: Experience from a case report

R. González-Maldonado, R. González-Redondo, C.G. DiCaudo (Granada, Spain)
The clinical significance of brain microbleed in Alzheimer’s disease patients with Parkinsonian signs

J.Y. Ahn, H.T. Kim (Seoul, Korea)
The CNS moving voice program: Implementation of a dual voice and physical exercise program for Parkinson’s disease: An applicability study

R. Loureiro, J. Domingos, D. Peralta, J. Dean, J. Ferreira (Lisbon, Portugal)
The cognitive profile of idiopathic REM sleep behavior disorder

L. Bernier-Lalonger, F. Escudier, P.A. Bourgouin, R.B. Postuma, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)
The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson’s disease

S.B. Koh, S.H. Kang, H.M. Lee, W.K. Seo, J.H. Kim (Seoul, Korea)
The communicative effectiveness survey-revised (CESR): An objective measure of communicative participation for people with Parkinson’s disease

N.J. Donovan (Baton Rouge, LA, USA)
The condition of cerebral hemodynamics in the secondary vascular parkinsonism

D. Akramova, A. Umarov, G. Rakhimbaeva, M. Ataniyazov, D. Shosaidova (Tashkent, Uzbekistan)
The contribution of the subthalamic nucleus in gait initiation of subjects with Parkinson’s disease

C. Palmisano, G. Arnulfo, N.G. Pozzi, A. Canessa, A. Leporini, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)
The core assessment program for surgical interventional therapies in Parkinson’s disease (CAPSIT-PD): Tolerability of preoperative neuropsychological testing for deep brain stimulation in Parkinson’s disease

G.D. Pal, V. Persinger, B. Bernard, B. Ouyang, C. Goetz, L. Verhagen (Chicago, IL, USA)
The correlation between dietary fiber, fluid intake and constipation in patients with Parkinson’s disease

N. Kawashima, A. Tabata, A. Kumon, K. Miyashita, A. Sato, H. Onuma, S. Nakamura, E. Horiuchi, K. Hasegawa (Fujisawa, Japan)
The correlation between N30 SEP and motor function in Parkinson’s disease

S.Y. Kang, Y.J. Kim, Y.H. Sohn, H.I. Ma (Hwaseong, Korea)
The differentiated treatment of Parkinson’s disease in patients with concomitant diabetes mellitus(DM) type 2

F.S. Akhmedova, M.K.U. Tukhtamishev (Tashkent, Uzbekistan)
The distinguishing clinical features of rapid-onset-parkinson-dystonia (RDP) syndrome due to ATP1A3 mutations

I.A. Meijer, R.A. Ortega, D. Raymond, N. Lubarr, V. Shanker, W.L. Severt, S. Bressman, L. Ozelius, R. Saunders-Pullman (New York, NY, USA)
The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale

L.S. Croll, K.M. Montgomery, C.V. Kulick, M.J. Nirenberg (New York, NY, USA)
The effect of a structured medication review on quality of life in patients with Parkinson’s disease. An interim analysis

A. Verbeek, N. Oonk, E. Munster, K. Movig, K. ter Huurne, H. Nijmeijer, J. van der Palen, L. Dorresteijn (Eerbeek, Netherlands)
The effect of an eight-week mindfulness training intervention on emotion related brain activation in people with Parkinson’s disease

B.A. Pickut, W. Van Hecke, P. Cras, E. Kerckhofs, S. Vanneste, D. Crosiers, P. Marien, P.M. Parizel (Grand Rapids, MI, USA)
The effect of anodal transcranial direct current stimulation (tDCS) on sequential motor skill learning in persons with Parkinson’s disease

E. Kerckhofs, N. Deroost (Brussels, Belgium)
The effect of daytime working for development of sleep apnea in office workers

D.M. Sultonov, U.N. Vokhidov (Tashkent, Uzbekistan)
The effect of dopamine on global versus specific inhibitory control in Parkinson’s disease

D. Kuebler, H. Schroll, R. Eva, A. Diepold, C. Meyer, A. Kuhn (Berlin, Germany)
The effect of dopaminergic therapy on stimulus-response learning and decision-making in Parkinson’s disease using fMRI

P.A. MacDonald, N.M. Hiebert, K.N. Seergobin, A.M. Owen (London, ON, Canada)
The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients

N. Ongun, C. Erdogan, E. Degirmenci, L.S. Bir (Denizli, Turkey)
The effect of levodopa-carbidopa intestinal gel on activities of daily living: Results from the observational MONOTREAT study in advanced Parkinson’s disease patients

R. Krüger, P. Lingor, T. Doskas, J. Henselmans, E.H. Danielsen, O. de Fabregues, A. Stefani, S.C. Sensken, J.C. Parra Riaza, K. Onuk, A. Yegin (Tübingen, Germany)
The effect of Mozart piano sonata on Parkinsonian tremor, rigidity and bradykinesia

A. Shoeybi, N. Olfati (Mashhad, Islamic Republic of Iran)
The effect of short pulse width neurostimulation in GPi-DBS

K. Kimura, H. Kishida, N. Ueda, K. Hamada, T. Kawasaki, F. Tanaka (Yokohama, Japan)
The effect of statin use on cognition in Parkinson’s disease

B.L. Deck, J. Rick, S.X. Xie, A. Chen-Plotkin, J.E. Duda, J.F. Morley, L.M. Chahine, N. Dahodwala, R.S. Akhtar, J.Q. Trojanowski, D. Weintraub (Philadelphia, PA, USA)
The effect of STN-DBS on movement initiation control is modulated by the noradrenergic system: Evidence of an interaction from a combined pharmacological/DBS/EEG study

C. Spay, M. Albares, S. Thobois, E. Broussolle, P. Boulinguez, B. Ballanger (Bron, France)
The effect of uni- and bilateral thalamic deep brain stimulation on speech in patients with essential tremor: Acoustics and intelligibility

J. Becker, T.B. Roettger, M. Hartinger, D. Mücke, A. Hermes, J. Pochmann, T.A. Dembek, J. Wirths, N. Allert, V. Visser-Vandewalle, I.G. Meister, M. Grice, L. Timmermann, M.T. Barbe (Cologne, Germany)
The effect of walking speed on postural stability in Parkinson’s disease fallers

M.H. Cole, M. Sweeney, Z.J. Conway, T.D. Blackmore, P.A. Silburn (Virginia, Australia)
The effectiveness of deep brain stimulation on dystonia: A meta-analysis

A.K.D. Antonio, E.A. Barcelon, P.M.D. Pasco (Manila, Philippines)
The effects of 60 Hz frequency of STN-DBS on gait in Parkinson’s disease

H. Brozová, K. Peterová, E. Ruzicka, J. Rusz, E. Plananská, L. Brabcová, R. Jech (Prague 2, Czech Republic)
The effects of deep brain stimulation for Parkinson’s disease on cognition and perceived quality of life: Preliminary results from an Ecuadorian sample

M.B. Jurado Noboa, R. Santibañez Vásquez, J. Achi, M. Navarrete, C. Mawyin (Guayaquil, Ecuador)
The effects of dysphagia course for speech & language pathologist in Israel on clinical-related knowledge and confidence

Y. Manor, H. Shabtai, O. Sella (Tel-Aviv, Israel)
The effects of fluvoxamine maleate in a post-natal stress rat model of neurodegeneration

E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)
The effects of gait and balance training on walking economy in early and mid stage Huntington’s disease

J.L. Kubica, J. Szymura, E. Mirek, M. Filip, M. Wiecek, M. Maciejczyk, M. Rudzinska, U. Pustulka-Piwnik, J. Stozek, S. Pasiut (Krakow, Poland)
The effects of intensive speech treatment on intelligibility in Spanish dysarthria secondary to Parkinson’s disease

G. Moya-Gale, E. Levy (New York, NY, USA)
The effects of viral priming on neurotoxin induced neurodegeneration and synapse dysfunction in cell culture models relevant to Parkinson’s disease

L.K. Olsen, E. Dowd, D. McKernan (Galway, Ireland)
The efficacy of quantitative ^99mTc-TRODAT-1 SPECT in diagnosis of aged patients with Parkinson’s disease

C.F. Lee, C.Y. Wei, G.U. Huang, I.J. Chen, B. Hsu (Changhua, Taiwan)
The efficacy of tremor detection and suppression device in intractable rest tremor in patients with Parkinson’s disease

O. Jitkritsadakul, C. Thanawattano, C. Anan, R. Bhidayasiri (Bangkok, Thailand)
The epigenetic regulation of HIF-1α by SIRT1 in MPP+ treated SH-SY5Y cells

Y. Wu, S. Dong, Y. Guo, Y. Feng, X. Cui, S. Kuo, T. Liu (Shanghai, People's Republic of China)
The evaluation of metabolic differences by using 18F-FDG-PET/CT in demented and non demented Idiophatic Parkinson’s disease patients

S. Altinayar, M. Bakir, Y. Demirtas, Y. Kaplan (Malatya, Turkey)
The evolution of REM sleep behavior disorder in Parkinson’s disease: The DeNoPa cohort at 2-year follow-up

F. Sixel-Döring, J. Zimmermann, A. Wegener, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)
The Faroese Parkinson’s diseases research program-Multifactorial analyses of a complex syndrome

M.S. Petersen, S. Bech, E. Nosova, L.L. Farrell, I. Guella, D. Evans, B. Ritz, J. Aasly, M.J. Farrer (Tórshavn, Faroe Islands)
The feasibility of measuring fatigability in early-stage Parkinson’s disease using functional MRI

Y. Xing, N. Bajaj, S.T. Schwarz, D.P. Auer (Nottingham, United Kingdom)
The finger tapping and disrupted smooth pursuit to detect the hepatic encephalopathy: Results of the subgroup analysis of movement disorders in non-Wilsonian hepatic cirrhotic patients

K. Methawasin, P. Chonmaitree, C. Wongjitrat, S. Rattanamongkolgul, T. Asawavichienjinda (Ongkharak, Thailand)
The French experience of liver transplantation for severe neurological forms of Wilson disease

A. Poujois, R. Sobesky, W. Meissner, E. de Medeiros, C. Vanlemmens, A.S. Brunet, E. Broussolle, J.C. Duclos-Vallée, F. Woimant (Paris, France)
The heterogeneity of fatigue in different stages of Parkinson’s disease

M.R. Nodel, N.N. Yakhno (Moscow, Russia)
The high prevalence of pain among patients with X linked dystonia parkinsonism

P.J.B. Acuna, C.L. Go (Boston, MA, USA)
The impact of a movement disorders specialist on resident knowledge, as measured by the resident in-service training examination (RITE)

A. Killoran (Morgantown, WV, USA)
The impact of levodopa and apomorphine on beta- and gamma-oscillations in cortico-basal ganglia circuits in experimental parkinsonism

J. Kühn, J.K. Haumesser, P.J. Magill, A.A. Kühn, V.V. Nikulin, C. van Riesen (Berlin, Germany)
The impact of STN DBS on kinetic tremor in Parkinson’s disease patients

S. Szlufik, M. Szumilas, J. Dutkiewicz, D. Koziorowski, T. Mandat, E. Slubowska (Warsaw, Poland)
The importance of Ishihara testing in early diagnosing of Parkinson’s disease

S. Mirdedaev, K. Mirzayeva, D. Baykhonova (Tashkent, Uzbekistan)
The improvement of a tardive diskinesia movements by inline skating

S.C.B. Casagrande, R.G. Cury, A.C.d.L. Pardini, D.B. Coelho, C.d.O. Souza, T.G. de Oliveira, M.G.d.S. Ghilardi, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)
The inflammatory burden of tic onset in a paediatric cohort: A preliminary study

A. Capuano, F. Nicita, M. Angeloni, F. Vigevano (Rome, Italy)
The influence of cerebellar transcranial direct current stimulation on skill acquisition in Parkinson’s disease

L. Lima de Albuquerque, K. Fischer, S. Jalene, M.R. Landers, B. Poston (Las Vegas, NV, USA)
The influences of STN-DBS and levodopa on cardiovascular autonomic function in patients with Parkinson’s disease: Evaluated by trigonometric regressive spectral analysis

K. Li, M. Wolz, R. Haase, H. Reichmann, T. Ziemssen (Dresden, Germany)
The initial motor symptom of Parkinson’s disease in relation to age at onset and gender: A Sri Lankan perspective

V. Suriyakumara, R. Gamage, H. Gunasekara, T. Fernando, A. Jayasuriya, R. Wijeyekoon, T. Muthukuda, R. De Silva (Nugegoda, Sri Lanka)
The interactive walkway: Towards assessing gait-environment interactions in a clinical setting

D.J. Geerse, M. Roerdink, B. Coolen, J. Marinus, J.J. van Hilten (Leiden, Netherlands)
The International Parkinson and Movement Disorder Society – non-motor rating scale (MDS-NMS): Results from the cognitive pre-testing and phases 1 and 2 of an international validation

K. Ray Chaudhuri, D. Weintraub, A. Schrag, P. Martinez-Martin, On behalf of EUROPAR, The MDS Non-Motor PD Study Group (London, United Kingdom)
The interrater variability in clinical assessment of post-hypoxic myoclonus

J.C. van Zijl, M. Beudel, J.W.J. Elting, B.M. de Jong, J. van der Naalt, W.M. van den Bergh, A.O. Rossetti, M.A.J. Tijssen, J. Horn (Groningen, Netherlands)
The kinase Fyn mediates levodopa induced dyskinesias in Parkinson´s disease

J.E. Ferrario, S. Sanz-Blasco, M. Bordone, A. Damianich, A. Bernardi, G. Gomez, I. Taravini, E. Avale, O. Gershanik (Buenos Aires, Argentina)
The long-term follow-up of subthalamic nucleus deep brain stimulation comparing medication alone in advanced Parkinson’s disease patients

S.H. Lin, S.Y. Chen, F.S. Jaw (Hualien, Taiwan)
The Luxembourg Parkinson’s study: Integrating the Lewy body composite risk score into a longitudinal study

M. Kerschenmeyer, P. Kolber, G. Hipp, K. Roomp, S.K. Mosch, A. Schweicher, L. Longhino, M. Falz, V.P. Satagopam, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schreiner, R. Krüger (Belval, Luxembourg)
The method of biofeedback training for the patients with Parkinson’s disease

I.S. Goursky, S.A. Likhachev, V.V. Vashchylin (Minsk, Belarus)
The movement disorder associated with NMDAR-antibody encephalitis: An expert-rater video study

J.A. Varley, K.P. Bhatia, R.C. Dale, V. Fung, T. Granata, M.A.J. Tijssen, A. Lang, J.P. Lin, M. Lim, T. Lynch, N. Nardocci, K.D. Sethi, S.R. Irani (Oxford, United Kingdom)
The National Parkinson Foundation mentoring and networking program: Phase I the process

C.B. Hunter, P.R. Palmentera, B. Vernon, A. Silver, K. Arney, J. Fleisher, F. Cubillos (Houston, TX, USA)
The neurosteroid dehydroepiandrosterone sulfate (DHEAS) reverses the dopaminergic deficiencies in mild hepatic encephalopathy: A possible therapeutic issue for the management of parkinsonism in cirrhotic patients

O. El Hiba, H. Gamrani (Marrakesh, Morocco)
The NIC-PD-study –Baseline data of a randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson’s disease in Germany and the USA

W.H. Oertel, C. Brittinger, C. Kamp, K. Balthasar, K. Articus, M. Brinkman, C. Venuto, H. Mueller, M.M. Unger, K.M. Eggert, D. Vadasz, K. Kieburtz, J. Boyd (Marburg, Germany)
The non-motor side of the honey-moon period of Parkinson’s disease

R. Erro, M. Picillo, C. Vitale, M. Amboni, M. Moccia, M.T. Pellecchia, P. Barone (London, United Kingdom)
The non-motors symptoms in Parkinson’s disease patients with freezing of gait

H.C. Huang, M.K. Lu, C.H. Tsai (Taichung, Taiwan)
The novel COMT-inhibitor ODM-104 and optimized carbidopa in combination with modified release levodopa reduce levodopa fluctuation and increase minimum concentrations in healthy subjects, when compared to the standard carbidopa/levodopa/entacapone combination

J. Ellmen, J. Tuunainen, A. Holopainen, T. Sarapohja, M. Scheinin (Turku, Finland)
The nucleocytoplasmic transport of ataxin-3 as pathogenic mechanism in spinocerebellar ataxia type 3

T. Schmidt, A. Sowa, I.M. Martins, M. Abedi, Z. Wang, J. Schmidt, H. Tricoire, O. Riess (Tübingen, Germany)
The Parkinson progression marker initiative (PPMI) – Developing a comprehensive longitudinal biomarker dataset

Parkinson Progression Marker Initiative (New Haven, CT, USA)
The patient’s perspective: The effect of dopamine on Parkinson symptoms

H. Zach, M.F. Dirkx, J.W. Pasman, B.R. Bloem, R.C. Helmich (Vienna, Austria)
The patterns of olfactory function in Parksinson’s disease patients with mild cognitive impairment

J.W. Park, H.K. Yoon, M.H. Park, D.Y. Kwon (Ansan, Korea)
The phenotypic and genetic features of myoclonus-dystonia in six Saudi Arabian kindreds

S.A. Bohlega, A. Aldakheel, T. Alkhairallah, A. Alkhani, M. Almuhaizea, F. Alotaibi (Riyadh, Saudi Arabia)
The position of the conus medullaris and the prevalence of isolated lipoma of filum terminale in Parkinson’s disease

H. Mori, K. Shindo (Kurashiki, Japan)
The potential therapeutic effect of intranasal administration of stem cells in rotenone model of Parkinson’s disease in mice

M. El-Gamal, M. Salama, M. Sobh, M. Emam, A. Abdalla, A. Lotfy, D. Sabry, M. El-Qotb, M. Sobh (Mansoura, Egypt)
The practicalities of freezing of gait assessment methods

C. Stummer, E. Mallia, B. Debû, B.R. Bloem, M.U. Ferraye (Nijmegen, Netherlands)
The prevalence of constipation and irritable bowel syndrome in Parkinson’s disease patients according to Rome III diagnostic criteria

T. Mishima, J. Fukae, S. Fujioka, K. Inoue, Y. Tsuboi (Fukuoka, Japan)
The prevalence of gastrointestinal disorders and non-motor symptoms in a cohort of patients with Parkinson’s disease

P.J. Hobson, J.R. Meara (Rhyl, United Kingdom)
The prevalence of non- motor symptoms in dystonia

P.M. de Carvalho Aguiar, F.P. da Silva-Junior, S.M. Azevedo Silva, E.R. Barbosa, V. Borges, M.S.G. Rocha, J.C.P. Limongi, H.B. Ferraz (Sao Paulo, Brazil)
The pull test in healthy subjects: Quantitative, posturographic and electromyographic analysis

J.R. Pérez-Sánchez, B. De La Casa-Fages, A. Contreras, J.M. Velázquez, A. Muñoz-González, F. Grandas (Madrid, Spain)
The regulation of ASIC1a on dopamine release and its implication in the pathogenesis of Parkinson’s disease

Y. Jing, L. Sha, L. Chunfeng, W. Fen (SuZhou, People's Republic of China)
The relation between dream content and non-motor symptoms in Parkinson’s disease and idiopathic REM sleep behavior disorder

P. Bugalho, T. Lampreia, R. Miguel, M. Mendonça, A. Caetano, R. Barbosa (Lisbon, Portugal)
The relationship among clinical features, DAT scintigraphy and MIBG cardiac scintigraphy in patients with Parkinson’s disease

J. Ebina, T. Sekiguchi, M. Takahashi, A. Inaba, S. Orimo (Tokyo, Japan)
The relationship between blood pressure, sex and survival in multiple system atrophy

T. Gurevich, A. Fisher, L. Markin, A. Rozenberg, E. Atanasova Mishkova- Serafimova, D. Klepikov, A. Ezra, J. Knaani, N. Giladi, C. Peretz (Tel Aviv, Israel)
The relationship between body composition and postural instability in idiopathic Parkinson’s disease

K.S. Diab, L.A. Hale, D.L. Waters, M.A. Skinner, G. Hammond-Took (Baghdad, Iraq)
The relationship between cognitive aspects (education status, executive function and verbal fluency) and motor aspects (balance and gait) in patients with Parkinson’s disease

C.O. Souza, M.C. Voos, H.F. Chien, D.V. Francato, A.F. Barbosa, J.M. Greve, E.T. Fonoff, E.R. Barbosa (Sao Paulo, Brazil)
The relationship between cognitive task and postural stability in the early stages of Parkinson’s disease

M. Demirkiran, M. Erdem (Adana, Turkey)
The relationship between impulse control disorders and dyskinesia in Parkinson´s disease: The ALTHEA study

R.J. Vorovenci, L. Weis, R. Biundo, A. Antonini (Venice, Italy)
The relationship between the cognitive phenotype and 5-HT2A receptor in PD with visual hallucinations

S.S. Cho, A.P. Strafella, S. Duff-Canning, M. Zurowski, A.C. Vijverman, V. Bruno, C. de Aquino, M. Criaud, P.M. Rusjan, S. Houle, S.H. Fox (Toronto, ON, Canada)
The relevance of movement disorders gene panels in clinical practice: How many patients are we sorting out?

C. Barzaghi, C. Panteghini, M. Carecchio, A. Legati, V. Monti, C. Reale, F. Invernizzi, B. Garavaglia (Milan, Italy)
The role and underlying mechanisms of BAG3 in regulating autophagy in PC12 cells

Y.P. Yang, Y.L. Cao, C.J. Mao, F. Wang, L.F. Hu, C.F. Liu (Suzhou, People's Republic of China)
The role of acoustic salience in acoustic cueing and sound-based motor rehabilitation

B.G. Schultz, S.A. Kotz (Maastricht, Netherlands)
The role of active rehabilitation measures, for maintaining the quality of life of patients after stroke with movement disorders in the general practice conditions

G. Sadullaeva (Tashkent, Uzbekistan)
The role of cathepsin L involved in the activation of microglia and Parkinson’s disease

S. Xu, X. Yang, H. Zhang, Y. Qian, Q. Xiao (Shanghai, People's Republic of China)
The role of depression in suicidal ideation in a sample of patients with Parkinson’s disease

M.M. Dumitru (Iasi, Romania)
The role of diabetes mellitus and hyperglycemia in early de novo Parkinson’s disease patients

S. Polychronis, G. Pagano, M. Politis (London, United Kingdom)
The role of neuroinflammation in the development of Parkinson’s disease dementia

A. Kouli, R. Vuono, R.A. Barker, C.H. Williams-Gray (Cambridge, United Kingdom)
The role of non-steroidal anti-inflammatory use in symptomatic and asymptomatic LRRK2 G2019S mutation carriers

K.A. Wyman-Chick, M.J. Barrett, S.A. Sperling, C.A. Manning (Charlottesville, VA, USA)
The role of proprioceptive deficits as a mechanism of gait impairments in postural instability and gait disorder Parkinson’s disease subtype

M.P. Pereira, P.H.S. Pelicioni, Q.J. Almeida, L.T.B. Gobbi (Leuven, Belgium)
The role of striatal dopaminergic terminals in early de novo PD patients with speech impairment

S. Polychronis, G. Pagano, M. Politis (London, United Kingdom)
The role of the frontal lobe in complex walking among healthy older adults and patients with Parkinson’s disease: An fNIRS study

A. Mirelman, I. Maidan, F. Nieuwhof, H. Bernad-Elazari, M.F. Reelick, B.R. Bloem, N. Giladi, J.E. Deutsch, J.A.H.R. Claassen, J.M. Hausdorff (Tel Aviv, Israel)
The scale for assessment and rating of ataxia in early onset ataxia; always a reliable biomarker?

R. Brandsma, T.F. Lawerman, M.J. Kuiper, I.J. Lunsing, H. Burger, D.A. Sival (Groningen, Netherlands)
The score changes of clinical symptom assessment scales for multiple system atrophy in 2-3 years

M. Matsushima, I. Yabe, I. Takahashi, K. Sakushima, F. Nakano, M. Hirotani, T. Kano, K. Horiuchi, H. Houzen, H. Sasaki (Sapporo, Japan)
The sense of agency is altered in cervical dystonia

C. Delorme, E. Roze, D. Grabli, J.M. Mayer, B. Degos, M. Vidailhet, Y. Worbe (Paris, France)
The serum response factor SRF protect dopamine (DA) neurons in Parkinson’s disease partially by mediate autophagy through a beclin 1-dependent pathway

X. Cheng (Suzhou, People's Republic of China)
The small GTP-binding protein Rhes influences midbrain dopaminergic neurons: Behavioral and biochemical studies

A. Pinna, F. Napolitano, G. Costa, P.F. Porceddu, L. Contu, J. Wardas, M.A. Casu, A. Usiello, M. Morelli (Cagliari, Italy)
The social value of improvement in activities of daily living from levodopa-carbidopa intestinal gel use among the advanced Parkinson’s disease population

K. Sail, T. Shih, J. Sullivan, J. Yash, E. van Eijndhoven, C. Zadikoff, T. Marshall, D. Lakdawalla (Mettawa, IL, USA)
The spectrum of abnormal movements and predictors of outcome in anti-NMDA receptor encephalitis in Thai patients

K. Suksuchano, M. Apiwattanakul (Bangkok, Thailand)
The spectrum of CNS hyperexcitability in gluten-related disorders

M. Hadjivassiliou, G.D. Rao, P. Sarrigiannis (Sheffield, United Kingdom)
The study of clinical outcome of deep brain stimulation for the idiopathic Parkinson’s disease at 6 months follow-up

P. Papitak, M. Aphiwatthanakun, T. Srikijvilaikul, N. Limotai (Bangkok, Thailand)
The subthalamic nucleus activity during gait in Parkinson’s disease

A. Leporini, G. Arnulfo, N.G. Pozzi, C. Palmisano, J. Brumberg, A. Canessa, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)
The systemic synuclein sampling study (S4)

D. Jennings, C. Coffey, T. Beach, T. Foroud, C.H. Adler, B. Mollenhauer, J. Seibyl, D. Ecklund, S. Lasch, V. Arnedo, C. Kopil (New Haven, CT, USA)
The temporal relationship between premonitory sensations and tics compared to obsessions

V.C. Brandt, C. Beck, J. Hermanns, T. Bäumer, B. Zurowski, S. Anders, A. Münchau (Lübeck, Germany)
The unfolded protein response pathway as a possible therapeutic target for the synucleinopathies

J.H. Baek, E. Bereczki, D. Aarsland (Stockholm, Sweden)
The value of multi-slice computed tomography angiography in diagnosis of intracranial circulation in patients with vascular parkinsonism

M. Ataniyazov, G. Rakhimbaeva, K. Ataniyazova (Tashkent, Uzbekistan)
The value of preference-based measures of quality of life in people with Parkinson’s: A systematic review

Y. Xin, E. McIntosh (Glasgow, United Kingdom)
The visible leg tremor at standing is always orthostatic tremor?

E. Oh, J.G. Lim, Y.S. Kim (Daejeon, Korea)
The writer’s cramp and its connections with sensory deficits

F.C. Paquet, A. Kreisler, A. Bartolo (Fouquières-Lès-Lens, France)
Therapeutic effect of onabotulinumtoxinA (BoNT/A) in hemifacial spasm and trigeminal neuralgia post Ramsay Hunt Syndrome type II

R. López-Castellanos, R. López-Contreras (San Salvador, El Salvador)
Therapeutic potential of compounds preferring specific GABAA receptor subunits for the treatment of dystonia?

F. Richter, C. Bode, C. Spröte, A. Bauer, A. Richter (Leipzig, Germany)
Therapeutic protocol for Parkinson’s patient with freezing based on action observation plus sonification: Preliminary results

S. Mezzarobba, M. Grassi, M. Catalan, L. Pellegrini, R. Valentini, B. Krüger, P. Manganotti, P. Bernardis (Trieste, Italy)
Therapeutic yoga improves balance and balance confidence in Parkinson’s disease

F. Revilla, K. Woschkolup, A.A. Walter, B.L. Hawkins, E. Urrea-Mendoza, A.A. Schmid, J. Park, J. Sharp, M. VanPuymbroeck (Greenville, SC, USA)
Therapy escalation in Parkinson’s disease – The TEMP trial, a regional survey

F. Gandor, A. Kühn, J. Müller, F. Klostermann, T. Müller, D. Gruber, A. Lipp, A. Kivi, D. Kübler, F. Ehlen, G. Ebersbach (Beelitz-Heilstätten, Germany)
Theta burst repetitive transcranial magnetic stimulation in a case with cortical-basal ganglionic degeneration

A. Demirtas-Tatlidede, Z. Matur, B. Bilgic, H. Hanagasi, M. Emre, H. Gurvit, E. Oge (Istanbul, Turkey)
THK-5351 tau-tracer uptake in patients with clinically diagnosed progressive supranuclear palsy

S. Schönecker, M. Brendel, J. Havla, G. Höglinger, K. Bötzel, A. Danek, A. Rominger, J. Levin (Munich, Germany)
Three cases of neuronal intranuclear inclusion disease (NIID)

Y. Miyamoto, Y. Morita, K. Furuta, Y. Osaki, H. Arahata, A. Watanabe, N. Fujii, T. Iwaki, H. Furuya (Kochi, Japan)
Three distinct cases of methamphetamine induced movement disorders

T.A. Clark, J. Kraakevik (Portland, OR, USA)
Three-dimensional cytoarchitecture of the basal ganglia: Clinical applications of a computational pipeline for histology to MRI registration

E.J.L. Alho, M. Alegro, R.L. Deus, R.P. Reis, L.T. Grinberg, J.F. Pereira Jr, L. Zöllei, E. Amaro Jr., H. Heinsen, E.T. Fonoff (Sao Paulo, Brazil)
Tick disorders in children and differential diagnosis with progressive diseases of the nervous system

D. Aminova, K. a (Tashkent, Uzbekistan)
Tics exacerbations in middle-aged and older adults with Tourette syndrome: A case series

D. Robakis, D. Machado, E. Penney, E.D. Louis (New Haven, CT, USA)
Timing control of gait in essential tremor patients vs. age-matched controls

A.K. Rao, E.D. Louis, A.K. Rao (New York, NY, USA)
TMS-EEG markers of inhibitory deficits in Huntington’s disease

E. Casula, I. Mayer, S. Tabrizi, J. Rothwell, M. Orth (Rome, Italy)
TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells

X. Cheng, M. Wang (Suzhou, People's Republic of China)
To new method of tremor assessment

A.V. Boika (Minsk, Belarus)
Topiramate responsive adult-onset opsoclonus myoclonus ataxia syndrome

Y. Degirmenci, H. Kececi (Duzce, Turkey)
Tourette syndrome and attention deficit hyperactivity disorders

K. Aminov (Tashkent, Uzbekistan)
Tourette syndrome treated by continuous electrical neuromodulation (DBS): Targeting the comorbidities?

F. Cyprien, L. Cif, V. Gonzalez, E. Sanrey, J. Perez, P. Coubes (Montpellier, France)
Toward a new biomarker on Parkinson’s disease: Study of alpha synuclein on upper enteric system by endoscopy

N. Ben Ali, S. Mrabet, S. Hawet, R. Debbiche, S. Belal (Tunis, Tunisia)
Toward clinical use of electrode localizations in deep brain stimulation therapy

S. Ewert, A. Horn, P. Plettig, M. Ruch, A. Kühn (Berlin, Germany)
Towards a responsive deep brain stimulation for the treatment of essential tremor

E. Opri, J. Shute, R. Molina, M. Okun, A. Gunduz, K. Foote (Gainesville, FL, USA)
Tracking Parkinson’s disease over 2-6 years with MRI

T.R. Melzer, D.J. Myall, M.R. MacAskill, L. Livingston, T.L. Pitcher, K. Wood, R.J. Keenan, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)
Tractographic patterns of effective pallidal DBS in DYT-6 Dystonia: A case study

L. Huang, N. Vanegas-Arroyave, K.A. Zaghloul, M. Hallett, S.G. Horovitz, C. Lungu (Bethesda, MD, USA)
Tractography patterns of subthalamic nucleus deep brain stimulation

N.S. Vanegas-Arroyave, P.M. Lauro, L. Huang, M. Hallett, S. Horovitz, K.A. Zaghloul, C. Lungu (New York, NY, USA)
Tractography study of individuals with mutation for Huntington’s disease in symptomatic and pre-symptomatic phases

R.A. Saba, J. Yared, T. Doring, V. Borges, L.B. Barcelos, H.B. Ferraz (São Paulo, Brazil)
Traditional trial-and-error versus neuroanatomical-3D-image software-assisted deep brain stimulation programming in patients with Parkinson’s disease

N. Pavese, S. Rodemark, Y.F. Tai, N. Yousif, D. Nandi, P.G. Bain (London, United Kingdom)
Trajectories of prediagnostic functioning in Parkinson’s disease during 14 years before clinical onset

S. Darweesh, V. Verlinden, B. Stricker, A. Hofman, P. Koudstaal, M.A. Ikram (Rotterdam, Netherlands)
Transcranial sonography and cognitive dysfunction in Parkinson’s disease

S. Behnke, A. Pilotto, I. Liepelt-Scarfone, R. Yilmaz, C. Pausch, S. Dieterich, I. Posner, J. Spiegel, U. Dillmann, M. Unger, B. Schmidl, J. Bürmann, K. Fassbender, D. Berg (Homburg Saar, Germany)
Transcranial sonography of the substantia nigra and its correlation with iron metabolism and c-reactive protein in Parkinson’s disease

X. Yang, J. Liu, Y. Qian, S. Xu, Q. Xiao (Shanghai, People's Republic of China)
Transcranial static magnetic field stimulation (tSMS) decreases motor cortex excitability in Parkinson’s disease OFF but not ON medication

M. Dileone, M. Carrasco-López, J. Segundo-Rodriguez, L. Mordillo-Mateos, N. López-Aristegui, F. Alonso-Frech, M. Catalan-Alonso, J. Obeso, A. Oliviero, G. Foffani (Madrid, Spain)
Transcranial unilateral MR guided high intensity focused ultrasound in Parkinson’s disease or essential tremor seems to be save concerning dysphagia and dysarthria

S. Hägele-Link, N.A. Wegener, S.R. Schreglmann, J. Rosenfeld, M. Mueller-Baumberger, R. Bauer, A. Lebeda, B. Werner, E. Martin, G. Kägi (St. Gallen, Switzerland)
Transcranial versus root repeated magnetic stimulation as a treatment of psychogenic movement disorders

B. Garcin, C. Hubsch, L. Lliescu, L. Naccache, M. Vidailhet, E. Fournier, F. Mesrati, E. Roze, B. Degos (Paris, France)
Transcriptional profile of blood leukocyte in Parkinson’s disease patients after multi-modal exercise and tai chi training

L. Jin, Y. Hu, T. Zhang, K. Zhang, Z. Nie, F. Chen, Q. Cai, S. Li (Shanghai, People's Republic of China)
Transient hemiballismus in a fast jet pilot

T. Coysh, D.P. Breen, P. Hodkinson (Stevenage, United Kingdom)
Transient mild hyperglycemia as diagnostic tool for idiopatic Parkinson’s disease triggered by psychoemotional stress

M.N. Khanova, K.A. Rasulova (Tashkent, Uzbekistan)
Transient myoclonic state in the elderly: A new entity in the classification of myoclonus

T. Hashimoto, T. Doden, H. Sato (Matsumoto, Japan)
Transient parkinsonism during pregnancy in patient heterozygous for Gaucher’s disease: Case report

S. Patel, K. Appleby, H. Fernandez (Cleveland, OH, USA)
Transient, symptomatic, non-infectious hypodensity around deep brain stimulation electrode

F. Alonso-Frech, J.A. Barcia Albacar, M.J. Catalán Alonso, C. Fernández, E. López Valdes, M. Yus (Madrid, Spain)
Translation of the European physiotherapy guideline for Parkinson’s disease to Portuguese

T.T.C. Capato, L.R.S. Almeida, J.M.M. Domingos, B. Bolem, S. Keus (São Paulo, Brazil)
Treating Parkinson’s 2015–A nationwide survey of treatment responses and complications in 1000 Irish patients with Parkinson’s disease

C. Stubbe, P. Bogdanova-Mihaylova, N. Kavanagh, K. Mulpeter, D. Bradley, T. Lynch, T. Counihan, P. Brown, S. O'Sullivan, R.A. Walsh (Dublin, Ireland)
Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia

R.R. Umarov, N.G. Sokhibnazarov (Tashkent, Uzbekistan)
Treatment of lipopolysaccharide-induced parkinsonism

I. Niehaus (Rendsburg, Germany)
Treatment of OFF episodes in Parkinson’s disease: An evaluation of patient and caregiver insights

E.J. Pappert, N. deGruyther, A. Agro (Toronto, ON, Canada)
Treatment of OFF episodes in Parkinson’s disease: An evaluation of physician practices

E.J. Pappert, A. Agro, N. deGruyther (Toronto, ON, Canada)
Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia

N.G. Sokhibnazarov, F.K. Shermukhamedova (Tashkent, Uzbekistan)
Tremor amplitude detected by three-dimensional optical device provides good correlation to clinical rating scale

K.H. Chen, P.C. Lin, Y.J. Chen, B.S. Yang, C.H. Lin, R.M. Wu (Hsin-Chu, Taiwan)
Tremor frequency by iPhone® applications: Correlation with EMG analysis

R. Araújo, M. Pereira, A. Matos, L. Negrão, A. Morgadinho (Coimbra, Portugal)
Tremor-recording methods and related quantitative tremor parameters in Parkinson’s disease

A. Kovács, Z. Farkas, A. Kamondi (Budapest, Hungary)
Triad-conditioning transcranial magnetic stimulation in focal hand dystonia

T. Popa, R. Hunt, O. Ahmad, K. Mente, R. Paine, M. Hallett (Bethesda, MD, USA)
Triple stimulation technique findings in patients with Parkinson’s disease and multiple system atrophy

H. Wang, Q. Ding, J. Yuan, L. Cui (Beijing, People's Republic of China)
Triple X syndrome: Are tremors part of its phenotype?

X. Garcia, M.E. Mohammad, H. Fernandez, I. Itin (Cleveland, OH, USA)
Turkish version of the Johns Hopkins restless legs syndrome quality of life questionnaire (RLS-QoL): Validity and reliability study

S. Güler, F.N. Turan (Edirne, Turkey)
Twelve-week sensor assessment in Parkinson’s disease: Impact on quality of life

J.M.T. Van Uem, K.S. Maier, A.T. Santos, O. Fagerbakke, F. Larsen, J.J. Ferreira, W. Maetzler (Tübingen, Germany)
Two cases of parkinsonism with atypical genetics

J.A. Ribeiro, F. Moreira, J. Beato-Coelho, A.S. Morgadinho, M.R. Almeida, C. Januário (Coimbra, Portugal)
Two new cases of a novel ovario-leukodystrophy related to AARS2 mutation from Korea

H.J. Yang, J.M. Lee, J.H. Kwon, S.T. Lee, H.J. Kim, B. Jeon (Ulsan, Korea)
Two siblings with action myoclonus renal failure syndrome

M. Tábuas-Pereira, J. Durães, J. Tomás, A. Gouveia, C.S. Miranda, M.C. Macário (Coimbra, Portugal)
Two years after unilateral Forel’s H campotomy for Parkinson’s disease: Quality of life, motor and cognitive outcomes of eleven patients

F. Godinho, M.O. Oliveira, P. Terzian, C. Costa, P. Gordon, M.S. Rocha (São Paulo, Brazil)
Two-step induction of dopaminergic neurons – Differentiation of leukapharesis-derived mesenchymal stem cells

S.I. El-Jaafary, M.M. Abdel-Dayem, N.M. Salama, H. Gabr, A.S. Abdelhafiz, Z.M. Ismail (Cairo, Egypt)
Types of farming and prevalence and incidence of Parkinson’s disease: French nationwide study

S. Kab, J. Spinosi, L. Chaperon, A. Dugravot, A. Singh-Manoux, F. Moisan, A. Elbaz (Saint-Maurice, France)